^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Ovidrel (choriogonadotropin alfa)

i
Other names: rhCG
Associations
Company:
EMD Serono
Drug class:
Ovarian follicle modulator
Associations
over2years
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS (clinicaltrials.gov)
P1, N=144, Recruiting, University of Virginia | Trial completion date: May 2024 --> May 2026 | Trial primary completion date: Apr 2024 --> Apr 2026
Trial completion date • Trial primary completion date
|
Ovidrel (choriogonadotropin alfa)
over2years
Ovarian Contribution to Androgen Production in Adolescent Girls (clinicaltrials.gov)
P=N/A, N=80, Active, not recruiting, University of Virginia | Recruiting --> Active, not recruiting | Trial completion date: Dec 2022 --> Dec 2025 | Trial primary completion date: Dec 2022 --> Dec 2025
Enrollment closed • Trial completion date • Trial primary completion date
|
Ovidrel (choriogonadotropin alfa) • dexamethasone injection